FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
PMA: P140010
·
Supplement: S091
·
Decision Jan 30, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0
Research PMA P140010 in seconds
The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Trade Name
- IN.PACT Admiral Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter and IN.PACT 018 Paclitax
- PMA Number
- P140010
- Supplement Number
- S091
- Device Class
- FDA Class 3
- Product Code
- ONU
- Generic Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- January 30, 2026
- Date Received
- April 7, 2025
- Supplement Type
- 135 Review Track For 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
a visual system with a reticulate as a manufacturing aid during the catheter subassembly welding manufacturing step to aid in ensuring proper overlap between two of the device components
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| ONU | Drug-Eluting Peripheral Transluminal Angioplasty Catheter | FDA class 3 | Unknown |